Capricor Therapeutics, Inc. (CAPR)
29.00
-0.81
(-2.72%)
USD |
NASDAQ |
May 15, 15:19
Capricor Therapeutics Shareholders Equity (Quarterly) : 278.70M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 6.068M |
| Vaxart, Inc. | 94.12M |
| Allogene Therapeutics, Inc. | 278.88M |
| REGENXBIO, Inc. | 21.08M |
| Replimune Group, Inc. | 210.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 326.28M |
| Total Liabilities (Quarterly) | 47.58M |
| Debt to Equity Ratio | 0.0758 |
| Current Ratio | 8.416 |
| Net Debt Paydown Yield | -0.19% |